D. Enders, S. Wallert / Tetrahedron Letters 43 (2002) 5109–5111
5111
3. (a) Cavagna, F.; Koller, W.; Linkies, A.; Rehling, H.;
Reuschling, D. Angew. Chem. 1982, 94, 549–550; (b)
Szymonifka, M. J.; Heck, J. V. Tetrahedron Lett. 1989,
30, 2869–2872; (c) Schwenkkraus, P.; Merkle, S.; Otto, H.
H. Liebigs Ann. Rec. 1997, 1261–1266; (d) Schwenkkraus,
P.; Otto, H. H. Arch. Pharm. 1993, 326, 437–441; (e)
Schwenkkraus, P.; Otto, H. H. Arch. Pharm. 1993, 326,
519–523; (f) Gordeev, M. F.; Gordon, E. M.; Patel, D. V.
J. Org. Chem. 1997, 62, 8177–8181.
(12 mL/mmol (S)-3a–e). The solution was stirred for 2 h
while it was allowed to warm up to room temperature.
After separation of the organic layer the aqueous phase
was extracted with CH2Cl2 (3×30 mL/mmol (S)-3a–e).
After drying over MgSO4 the solvent was evaporated and
the products were purified by column chromatography
(SiO2, n-pentane/diethylether) to afford (S)-4a–e.
9. Selected analytical and spectroscopic data of compounds
(S)-3 and (S)-4. Analytic data of compound (S)-3e: 1H
NMR (400 MHz, CDCl3): l=2.10 (m, 2H, CH2CH2Ph),
2.67 (m, 2H, CH2CH2Ph), 3.83 (dd, J=14.0 Hz, J=3.9
Hz, 1H, SO2CHH), 4.05 (dd, J=14.2 Hz, J=6.7 Hz, 1H,
SO2CHH), 4.15 (m, 1H, SO2CH2CH), 5.09 (s, 2H,
OCH2), 5.42 (d, J=8.2 Hz, 1H, NH), 7.10–7.36 (m, 10H,
Har); 13C NMR (100 MHz, CDCl3): l=32.5, 35.3, 48.6,
67.5, 68.9, 126.7, 128.4, 128.6, 128.9, 128.9, 136.3, 140.3,
155.8; MS (EI): m/z 381, 290, 186, 142, 129, 108, 104, 91,
65; IR (KBr): 3676, 3653, 3590, 3331, 3062, 3030, 2927,
2861, 1695, 1541, 1498, 1454, 1383, 1356, 1285, 1255,
1212, 1166, 1083, 1049, 907, 847, 774, 743, 697, 608, 528
cm−1; Anal. calcd for: C18H20ClNO4S: C, 56.61; H, 5.28;
N, 3.67. Found: C, 56.69; H, 5.50; N, 3.36%.
4. Beardsell, M.; Hinchliffe, P. S.; Wood, J. M.; Wilmouth,
R. C.; Schofield, C. J.; Page, M. I. J. Chem. Soc., Chem.
Commun. 2001, 497–498.
5. Trentmann, W.; Mehler, T.; Martens, J. Tetrahedron:
Asymmetry 1997, 8, 2033–2043.
6. Baldoli, C.; Del Buttero, P.; Perdicchia, D.; Pilati, T.
Tetrahedron 1999, 55, 14089–14096.
7. Wallert, S.; Enders, D. Synlett 2002, 304–306.
8. General procedure for the preparation of compounds
(S)-3 and (S)-4.
Synthesis of N-Cbz-protected b-amino-sulfonyl chlorides
(S)-3a–e: N-Cbz-protected b-amino-sulfonates (S)-2 were
dissolved in EtOH (30 mL/mmol (S)-2) and refluxed for
15 h. After cooling to room temperature, 1.1 equiv.
NaOAc were added and the reaction mixture was stirred
for 1 h. The solvent was removed under reduced pressure
and the crude sodium salts were dissolved in abs. CH2Cl2
(10 mL/mmol (S)-2) and abs. DMF (0.12 mL/mmol
(S)-2) under argon atmosphere. Then a solution, contain-
ing 20% COCl2 in toluene (1 mL/mmol (S)-2) was added
dropwise to the reaction mixture. After stirring for 2 h at
room temperature the products were purified by column
chromatography (SiO2, CH2Cl2) to afford b-amino-sulfo-
nyl chlorides (S)-3a–e.
1
Analytic data of compound (S)-4e: H NMR (400 MHz,
CDCl3): l=2.08 (m, 2H, CH2CH2Ph), 2.67 (m, 2H,
CH2CH2Ph), 3.59 (m, 1H, NHCH), 3.81 (dd, J=12.6 Hz,
J=5.5 Hz, 1H, SO2CHH), 4.22 (ddd, J=12.6 Hz, J=7.7
Hz, J=3.3 Hz, 1H, SO2CHH), 5.50 (s, 1H, NH), 7.13–
7.33 (kB, 5H, Har); 13C NMR (100 MHz, CDCl3): l=
32.7, 37.8, 40.8, 65.1, 126.8, 128.6, 129.0, 140.0; MS (EI):
m/z=211, 130, 106, 91, 77, 65, 51; IR (KBr): 3676, 3654,
3632, 3273, 3032, 2925, 2856, 1656, 1604, 1497, 1456,
1384, 1331, 1302, 1265, 1231, 1203, 1156, 1098, 1083,
1060, 1031, 972, 934, 805, 753, 701, 629, 572, 519, 479
cm−1; Anal. calcd for: C10H13NO2S: C, 56.85; H, 6.20; N,
6.63. Found: C, 56.58; H, 6.56; N, 6.22%.
Synthesis of b-sultams (S)-4a–e: b-amino-sulfonyl chlo-
rides (S)-3a–e were dissolved in CH2Cl2 (20 mL/mmol
(S)-3a–e). A 33% HBr in HOAc-solution was added (1.5
equiv.). After stirring for 3 h at room temperature the
reaction mixture was cooled to 0°C and NEt3 was added
10. All new compounds showed suitable spectroscopic data
(NMR, MS, IR) and correct elemental analyses.